Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Bayer AG
Deal Size : Undisclosed
Deal Type : Agreement
ConcertAI and Bayer Form Strategic Agreement for Precision Oncology Development
Details : The agreement enables Bayer to leverage ConcertAI Translational360 and AI SaaS Solutions to accelerate clinical development in precision oncology.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
April 22, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Bayer AG
Deal Size : Undisclosed
Deal Type : Agreement